1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
- 2017
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
-
Mark
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
(
- Contribution to journal › Article
- 2016
-
Mark
The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Splenic lymphocyte subtypes in immune thrombocytopenia : increased presence of a subtype of B-regulatory cells
(
- Contribution to journal › Article
- 2015
-
Mark
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
(
- Contribution to journal › Article
- 2014
-
Mark
Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
- 2013
-
Mark
Cellular immune dysfunction in immune thrombocytopenia (ITP)
(
- Contribution to journal › Article
- 2012
-
Mark
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia
(
- Contribution to journal › Article